Six-year duration of adjuvant imatinib in high-risk GIST: more to come.

Details

Language :

English

ISSN :

1569-8041

Volume :

36

Issue :

3

Database :

MEDLINE

Journal :

Annals of oncology : official journal of the European Society for Medical Oncology

Publication Type :

Editorial & Opinion

Accession number :

39631623

Full Text :

https://doi.org/10.1016/j.annonc.2024.11.013